|
|
|
Cel sci Corporation (NYSE: CVM) |
|
|
|
| |
Cel Sci Corporation's vs. its Competitors Results
(List of Competitors, Financial Results 12 Months from the last period ending MRQ, in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
REVENUE |
NET INCOME |
NET MARGIN |
CASH FLOW |
| Cel sci Corporation |
1 Q 2025 |
CVM |
0.00 |
-27.28 |
- |
1.37 |
| Amgen Inc |
4 Q 2024 |
AMGN |
33,424.00 |
4,090.00 |
12.24 % |
1,029.00 |
| Gilead Sciences Inc |
1 Q 2025 |
GILD |
28,735.00 |
5,965.00 |
20.76 % |
3,208.00 |
| Incyte Corporation |
1 Q 2025 |
INCY |
4,413.23 |
21.27 |
0.48 % |
-1,404.44 |
| Seagen Inc |
3 Q 2023 |
SGEN |
2,300.35 |
-750.23 |
-32.61 % |
60.79 |
| Exelixis Inc |
1 Q 2025 |
EXEL |
2,298.92 |
1,481.63 |
64.45 % |
-75.81 |
| Immunogen inc |
3 Q 2023 |
IMGN |
287.61 |
-73.52 |
-25.56 % |
296.02 |
| Iovance Biotherapeutics inc |
1 Q 2025 |
IOVA |
212.68 |
-375.36 |
-176.49 % |
37.43 |
| Cardiff Oncology Inc |
1 Q 2025 |
CRDF |
2.67 |
-48.85 |
-1831.11 % |
5.44 |
| Revolution Medicines Inc |
4 Q 2024 |
RVMD |
29.51 |
-600.09 |
-2033.52 % |
-152.42 |
| Ikena Oncology Inc |
1 Q 2025 |
IKNA |
30.38 |
-41.71 |
-137.27 % |
-16.50 |
| APROX. MARKET |
1 Q |
SUBTOTAL |
71,734.35 |
9,640.85 |
13.44 % |
2,987.52 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
